Answers are grounded in this paper and cite their sources.
Review reveals treatment gaps and emerging therapies for minimal residual disease in colorectal cancer, highlighting the need for novel regimens and surrogate endpoints.
: The management of early-stage colorectal cancer (CRC) is undergoing a significant transformation, from traditional clinical and pathological staging to a dynamic, molecular signature-driven approach utilizing circulating tumor DNA (ctDNA). Postoperative detection of minimal residual disease (MRD) has emerged as a strong independent prognostic biomarker. It identifies patients at high risk of recurrence while reducing unnecessary exposure to adjuvant chemotherapy for those cured by surgery alone. However, this success reveals a critical therapeutic dilemma. Standard adjuvant chemotherapy has a limited ability to eliminate MRD. Consequently, the molecularly defined high-risk subgroup currently has no proven therapy that effectively eradicates MRD and improves survival. In this review, we synthesize emerging therapeutic strategies designed to address this unmet need. Wediscuss ongoing clinical trials investigating intensified cytotoxic regimens, MRD-guided targeted therapies, and novel immunotherapy combinations, especially for microsatellite-stable (MSS) disease. Furthermore, this review examines the role of ctDNA dynamics as a surrogate endpoint for regulatory drug approval, a crucial step in accelerating the development of these novel therapies. Finally, we address the real-world challenges of implementation, including access disparities, equity gaps, and standardized clinical algorithms. We highlight how emerging technologies and global collaborations may further refine MRD detection. The eradication of MRD represents the next frontier in curing CRC; however, this demands focused clinical research and validated surrogate endpoints to translate prognostic insights into tangible survival benefits.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: